INBX - Inhibrx Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$325.00
DETAILS
HIGH:
$325.00
LOW:
$325.00
MEDIAN:
$325.00
CONSENSUS:
$325.00
UPSIDE:
211.71%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 1.3 | 0.2 | 1.8 | 2.2 | 7.1 | 12.8 | 9.1 | 7.5 | 8.0 | 6.7 |
| Cost of Revenue | 2.5 | 2.3 | 1.2 | 110.2 | 2.7 | 73.5 | 47.9 | 33.5 | 25.5 | 17.0 |
| Gross Profit | (1.2) | (2.1) | 0.6 | (108.0) | 4.4 | (60.7) | (38.8) | (26.0) | (17.6) | (10.3) |
| Operating Expenses | ||||||||||
| R&D Expenses | 113.0 | 203.7 | 190.6 | 110.2 | 71.4 | 73.5 | 47.9 | 33.5 | 25.5 | 17.0 |
| SG&A Expenses | 23.3 | 127.9 | 29.4 | 21.1 | 12.4 | 6.8 | 9.0 | 4.7 | 2.6 | 1.6 |
| Other Expenses | (2.5) | (2.3) | (0.2) | (110.2) | (71.5) | (0.1) | (4.1) | 0.1 | 0.0 | 0 |
| Operating Expenses | 133.8 | 329.4 | 219.8 | 21.1 | 12.3 | 80.3 | 52.8 | 37.0 | 27.7 | 18.6 |
| Operating Income | ||||||||||
| Operating Income | (135.0) | (331.4) | (219.2) | (129.1) | (76.6) | (67.4) | (43.7) | (29.5) | (19.7) | (12.1) |
| Interest Expense | 12.2 | 13.5 | 31.8 | 16.1 | 5.2 | 10.8 | 5.7 | 1.5 | 2.1 | 0 |
| Interest Income | 7.5 | 10.9 | 11.9 | 16.1 | 5.2 | 10.8 | 5.7 | 0 | 0 | 0.8 |
| Profitability | ||||||||||
| EBITDA | (132.5) | 1,703.3 | (206.7) | (125.8) | (75.4) | (63.8) | (42.6) | (28.8) | (19.3) | (11.9) |
| EBIT | (135.0) | 1,701.1 | (207.9) | (127.0) | (76.6) | (64.8) | (44.8) | (29.4) | (19.7) | (12.1) |
| Income Before Tax | (140.1) | 1,687.6 | (239.7) | (145.2) | (81.8) | (75.6) | (50.5) | (30.9) | (21.8) | (12.9) |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.1 | 0.2 | (4.6) |
| Net Income | (140.1) | 1,687.6 | (241.4) | (145.2) | (81.8) | (75.6) | (51.4) | (31.2) | (19.4) | (8.3) |
| Per Share Data | ||||||||||
| EPS (Basic) | -9.04 | 116.58 | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| EPS (Diluted) | -9.04 | 116.58 | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| Shares Outstanding | 15.5 | 14.5 | 47.1 | 40.1 | 38.0 | 25.3 | 36.6 | 27.1 | 28.8 | 36.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 124.2 | 152.6 | 277.9 | 273.9 | 131.3 | 128.7 | 11.5 | 2.1 | 13.5 | 20.0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0.2 | 0.4 | 0.8 | 0.3 | 0.9 | 0.6 | 0.4 | 0.7 | 0.7 | 0 |
| Inventory | 0 | 0 | 0 | 0 | (0.9) | (129.3) | 3.2 | 2.3 | 1.0 | 0 |
| Other Current Assets | 0.2 | 0.8 | 0.7 | 0.2 | 7.8 | 132.2 | 0.4 | 0.6 | 0.3 | 0.4 |
| Total Current Assets | 132.8 | 160.4 | 295.4 | 280.5 | 139.1 | 132.2 | 15.6 | 5.7 | 15.4 | 20.4 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 9.3 | 13.5 | 9.4 | 7.2 | 9.5 | 11.3 | 10.7 | 2.6 | 1.8 | 0.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.4 | 6.8 | 3.2 | 3.2 | 1.8 | 0.2 | 0.2 | 1.7 | 0 | 0 |
| Total Non-Current Assets | 13.6 | 20.4 | 12.5 | 10.4 | 11.3 | 11.6 | 10.9 | 4.3 | 1.8 | 0.9 |
| Total Assets | 146.5 | 180.8 | 307.9 | 290.9 | 150.4 | 143.7 | 26.5 | 10.0 | 17.2 | 21.3 |
| Current Liabilities | ||||||||||
| Account Payables | 5.9 | 9.2 | 11.0 | 8.3 | 9.1 | 13.5 | 3.1 | 6.5 | 0.8 | 0.2 |
| Short-Term Debt | 2.3 | 1.6 | 0 | 1.9 | 1.7 | 1.5 | 4.7 | 5.9 | 5.2 | 4.3 |
| Deferred Revenue | 0 | 0 | 0 | 0.2 | 2.0 | 3.1 | 7.9 | 1.6 | 2.6 | 0 |
| Other Current Liabilities | 18.1 | 7.7 | 6.5 | 13.8 | 9.6 | 13.4 | 4.8 | 2.1 | 0.4 | 0.9 |
| Total Current Liabilities | 33.8 | 40.7 | 56.3 | 27.6 | 22.5 | 31.4 | 20.6 | 16.2 | 8.9 | 5.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 100.6 | 0 | 207.0 | 202.1 | 70.5 | 36.0 | 37.1 | 3.6 | 9.5 | 14.7 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | (6.7) | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 5.0 | 0.2 | 68.1 | 47.9 | 21.3 | 0.1 |
| Total Non-Current Liabilities | 104.7 | 6.5 | 208.1 | 205.2 | 75.6 | 36.9 | 99.5 | 51.4 | 30.7 | 14.8 |
| Total Liabilities | 138.5 | 47.2 | 264.4 | 232.8 | 98.1 | 68.3 | 120.1 | 67.6 | 39.7 | 20.0 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (246.2) | (106.1) | (613.7) | (372.4) | (227.1) | (145.4) | (69.3) | (17.9) | (28.8) | (9.2) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | (150.4) | (143.7) | (59.5) | (1.7) | (1.0) | 0 |
| Total Stockholders' Equity | 8.0 | 133.6 | 43.5 | 58.1 | 52.4 | 75.5 | (93.6) | (57.6) | (28.8) | (9.2) |
| Total Liabilities & Equity | 146.5 | 180.8 | 307.9 | 290.9 | 150.4 | 143.7 | 26.5 | 10.0 | 17.2 | 21.3 |
| Debt Metrics | ||||||||||
| Total Debt | 107.0 | 8.0 | 210.1 | 207.1 | 72.1 | 37.5 | 41.7 | 9.5 | 14.7 | 18.9 |
| Net Debt | (17.2) | (144.5) | (67.8) | (66.8) | (59.2) | (91.2) | 30.2 | 7.4 | 1.2 | (1.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (140.1) | 1,687.6 | (239.7) | (145.2) | (81.8) | (76.1) | (51.4) | (31.0) | (22.1) | (8.3) |
| Depreciation & Amortization | 2.5 | 2.3 | 1.2 | 1.2 | 1.2 | 1.0 | 1.2 | 0.7 | 0.4 | 0.3 |
| Stock-Based Compensation | 11.1 | 58.5 | 24.8 | 20.4 | 15.0 | 5.0 | 4.0 | 2.5 | 1.2 | 0.6 |
| Change in Working Capital | (7.6) | 52.1 | 15.3 | 3.2 | (17.5) | 12.7 | 3.5 | 4.2 | 1.0 | (6.3) |
| Other Non-Cash Items | 4.3 | (1,994.8) | 5.0 | 5.1 | 2.7 | 11.6 | 9.6 | 0.5 | 0.7 | (3.4) |
| Operating Cash Flow | (129.8) | (194.4) | (193.3) | (115.3) | (80.3) | (48.0) | (32.1) | (23.1) | (18.8) | (18.1) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.0) | (2.6) | (4.6) | (0.7) | (0.9) | (1.4) | (1.8) | (1.4) | (1.3) | (0.2) |
| Acquisitions | 0.0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (0.0) | (2.6) | (4.6) | (0.7) | (0.8) | (1.4) | (1.8) | (1.4) | (1.3) | (0.2) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 99.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.8) | (1.4) | 0 |
| Other Financing Activities | 0 | 0 | 0 | 128.8 | 83.8 | 166.5 | 43.3 | 14.0 | 14.9 | 28.8 |
| Financing Cash Flow | 101.4 | 71.7 | 202.0 | 258.6 | 83.8 | 166.5 | 43.3 | 13.2 | 13.5 | 28.8 |
| Cash Position | ||||||||||
| Net Change in Cash | (28.4) | (125.3) | 4.1 | 142.6 | 2.6 | 117.1 | 9.4 | (11.4) | (6.6) | 10.4 |
| Cash at Beginning | 152.6 | 277.9 | 273.9 | 131.3 | 128.7 | 11.5 | 2.1 | 13.5 | 20.0 | 9.6 |
| Cash at End | 124.2 | 152.6 | 277.9 | 273.9 | 131.3 | 128.7 | 11.5 | 2.1 | 13.5 | 20.0 |
| Free Cash Flow | (129.8) | (197.0) | (197.9) | (116.0) | (81.2) | (49.3) | (33.9) | (24.5) | (20.1) | (18.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.3 | 0.2 | 1.8 | 2.2 | 7.1 | 12.8 | 9.1 | 7.5 | 8.0 | 6.7 |
| Gross Profit | (1.2) | (2.1) | 0.6 | (108.0) | 4.4 | (60.7) | (38.8) | (26.0) | (17.6) | (10.3) |
| Operating Income | (135.0) | (331.4) | (219.2) | (129.1) | (76.6) | (67.4) | (43.7) | (29.5) | (19.7) | (12.1) |
| Net Income | (140.1) | 1,687.6 | (241.4) | (145.2) | (81.8) | (75.6) | (51.4) | (31.2) | (19.4) | (8.3) |
| EPS (Diluted) | -9.04 | 116.58 | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 124.2 | 152.6 | 277.9 | 273.9 | 131.3 | 128.7 | 11.5 | 2.1 | 13.5 | 20.0 |
| Total Assets | 146.5 | 180.8 | 307.9 | 290.9 | 150.4 | 143.7 | 26.5 | 10.0 | 17.2 | 21.3 |
| Total Debt | 107.0 | 8.0 | 210.1 | 207.1 | 72.1 | 37.5 | 41.7 | 9.5 | 14.7 | 18.9 |
| Stockholders' Equity | 8.0 | 133.6 | 43.5 | 58.1 | 52.4 | 75.5 | (93.6) | (57.6) | (28.8) | (9.2) |
| Cash Flow | ||||||||||
| Operating Cash Flow | (129.8) | (194.4) | (193.3) | (115.3) | (80.3) | (48.0) | (32.1) | (23.1) | (18.8) | (18.1) |
| Capital Expenditure | (0.0) | (2.6) | (4.6) | (0.7) | (0.9) | (1.4) | (1.8) | (1.4) | (1.3) | (0.2) |
| Free Cash Flow | (129.8) | (197.0) | (197.9) | (116.0) | (81.2) | (49.3) | (33.9) | (24.5) | (20.1) | (18.3) |